@article{TLCR23670,
author = {Marius Ilie and Paul Hofman},
title = {Spotlight on tumor mutational burden in patients with non-small cell lung carcinoma},
journal = {Translational Lung Cancer Research},
volume = {7},
number = {6},
year = {2018},
keywords = {},
abstract = {In the last recent years, immune checkpoint inhibitors directed against programmed cell death-1 (PD-1) and its ligand programmed death-ligand 1 (PD-L1), have strongly changed the treatment paradigm of patients with non-small cell lung cancer (NSCLC).},
issn = {2226-4477}, url = {https://tlcr.amegroups.org/article/view/23670}
}